Peter D. Gorycki
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Melanoma and MAPK Pathways 3
- Phosphodiesterase function and regulation 3
- Oncology 12
- Drug Transport and Resistance Mechanisms 5
- Chemokine receptors and signaling 2
- Co-authors
- Don E. Griswold (3 shared papers)Edward F. Webb (3 shared papers)Theodore J. Torphy (3 shared papers)Paul Skett (1 shared paper)Gregory L. Kedderis (1 shared paper)Roger Rahmani (1 shared paper)Albert P. Li (1 shared paper)H.G. Koebe (1 shared paper)
- Journals
- Drug Metabolism and Disposition (5 papers)Xenobiotica (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Chemical Research in Toxicology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Peter D. Gorycki
29 papers receiving 697 citations
Peers
Comparison fields: 5 of 88
- Pharmacology 116
- Hepatology 65
- Oncology 166
- Organic Chemistry 146
- Molecular Biology 344
Countries citing papers authored by Peter D. Gorycki
This map shows the geographic impact of Peter D. Gorycki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Gorycki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Gorycki more than expected).
Fields of papers citing papers by Peter D. Gorycki
This network shows the impact of papers produced by Peter D. Gorycki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Gorycki. The network helps show where Peter D. Gorycki may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter D. Gorycki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 113 | |
| 2 | 1998 | 88 | |
| 3 | SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo. | 1998 | 76 |
| 4 | 2012 | 72 | |
| 5 | 1998 | 60 | |
| 6 | 2011 | 38 | |
| 7 | 2013 | 36 | |
| 8 | 1998 | 33 | |
| 9 | 2004 | 32 | |
| 10 | 2006 | 32 | |
| 11 | 1989 | 26 | |
| 12 | 2019 | 14 | |
| 13 | 1985 | 12 | |
| 14 | 1989 | 11 | |
| 15 | 2002 | 11 | |
| 16 | 2019 | 11 | |
| 17 | 2014 | 9 | |
| 18 | 2011 | 9 | |
| 19 | 2011 | 9 | |
| 20 | 1990 | 9 |
About Peter D. Gorycki
Peter D. Gorycki is a scholar working on Molecular Biology, Oncology, Pharmacology, Organic Chemistry and Infectious Diseases, having authored 29 papers that have together received 735 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Melanoma and MAPK Pathways (3 papers), Neuropeptides and Animal Physiology (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Phosphodiesterase function and regulation (3 papers), HIV/AIDS drug development and treatment (3 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Pharmacology (116 citations), Hepatology (65 citations), Oncology (166 citations), Organic Chemistry (146 citations) and Molecular Biology (344 citations). Peter D. Gorycki has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Don E. Griswold, Edward F. Webb, Theodore J. Torphy, Paul Skett, Gregory L. Kedderis, Roger Rahmani, Albert P. Li, H.G. Koebe, Yanli Deng and José M. Silva. Their work appears in journals such as Drug Metabolism and Disposition, Xenobiotica, Bioorganic & Medicinal Chemistry Letters, Chemical Research in Toxicology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.